STAT2/SLC27A3/PINK1-Mediated Mitophagy Remodeling Lipid Metabolism Contributes to Pazopanib Resistance in Clear Cell Renal Cell Carcinoma

被引:2
|
作者
Lu, Dingheng [1 ]
Li, Yuxiao [2 ]
Niu, Xinyang [1 ]
Sun, Jiazhu [1 ]
Zhan, Weitao [1 ]
Shi, Yuchen [1 ]
Yu, Kai [1 ]
Huang, Suyuelin [1 ]
Liu, Xiaoyan [2 ]
Xie, Liping [1 ]
Ma, Xueyou [1 ,3 ]
Liu, Ben [1 ,3 ]
机构
[1] Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou,310003, China
[2] Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou,310003, China
[3] Cancer Center, Zhejiang University, Zhejiang, Hangzhou,310003, China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Binding sites - Biomolecules - Coenzymes - Gene encoding - Light polarization - Metabolites - Mitochondria - Targeted drug delivery;
D O I
10.34133/research.0539
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 23 条
  • [1] Vascular mimicry induced by m6A mediated IGFL2-AS1/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma
    Bo Cheng
    Mingyue Xie
    Yong Zhou
    Tian Li
    Wanting Liu
    Wenjing Yu
    Man Jia
    Shuang Yu
    Lixuan Chen
    Rongyang Dai
    Ronghao Wang
    Cell Death Discovery, 9
  • [2] Vascular mimicry induced by m6A mediated IGFL2-AS1/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma
    Cheng, Bo
    Xie, Mingyue
    Zhou, Yong
    Li, Tian
    Liu, Wanting
    Yu, Wenjing
    Jia, Man
    Yu, Shuang
    Chen, Lixuan
    Dai, Rongyang
    Wang, Ronghao
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [3] Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma
    Chao Wang
    Yuning Wang
    Tianyu Hong
    Bing Cheng
    Sishun Gan
    Linbao Chen
    Jing Zhang
    Li Zuo
    Jian Li
    Xingang Cui
    Cell Death & Disease, 11
  • [4] Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma
    Wang, Chao
    Wang, Yuning
    Hong, Tianyu
    Cheng, Bing
    Gan, Sishun
    Chen, Linbao
    Zhang, Jing
    Zuo, Li
    Li, Jian
    Cui, Xingang
    CELL DEATH & DISEASE, 2020, 11 (02)
  • [5] PBX1 promotes the cell proliferation via JAK2/STAT3 signaling in clear cell renal carcinoma
    Wei, Xin
    Yu, Lili
    Li, Yi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 500 (03) : 650 - 657
  • [6] MIER2/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma
    Wei, Zhihao
    Ye, Yuzhong
    Liu, Chenchen
    Wang, Qi
    Zhang, Yunxuan
    Chen, Kailei
    Cheng, Gong
    Zhang, Xiaoping
    JOURNAL OF ADVANCED RESEARCH, 2025, 70 : 287 - 305
  • [7] TBC1D5 reverses the capability of HIF-2α in tumor progression and lipid metabolism in clear cell renal cell carcinoma by regulating the autophagy
    Huang, Yu
    Xiong, Zhiyong
    Wang, Jianjun
    Gao, Yafen
    Cao, Qi
    Wang, Decai
    Shi, Jian
    Chen, Zhixian
    Yang, Xiong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [8] IL1R2 promotes tumor progression via JAK2/STAT3 pathway in human clear cell renal cell carcinoma
    Liu, Yingting
    Xing, Zhaoyu
    Yuan, Maoling
    Xu, Bin
    Chen, Lujun
    Zhang, Dachuan
    Zhou, You
    Huang, Hao
    Zheng, Xiao
    Zhang, Jinping
    Jiang, Jingting
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 238
  • [9] IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma
    Jeong, Se Un
    Park, Ja-Min
    Yoon, Sun Young
    Hwang, Hee Sang
    Go, Heounjeong
    Shin, Dong-Myung
    Ju, Hyein
    Sung, Chang Ohk
    Lee, Jae-Lyun
    Jeong, Gowun
    Cho, Yong Mee
    INVESTIGATIVE AND CLINICAL UROLOGY, 2024, 65 (01) : 84 - 93
  • [10] ERβ-Mediated Alteration of circATP2B1 and miR-204-3p Signaling Promotes Invasion of Clear Cell Renal Cell Carcinoma
    Han, Zhenwei
    Zhang, Yong
    Sun, Yin
    Chen, Jiaqi
    Chang, Chawnshang
    Wang, Xiaolu
    Yeh, Shuyuan
    CANCER RESEARCH, 2018, 78 (10) : 2550 - 2563